Category Archives: Direct-to-Consumer

AMA Moves to Ban Direct-To-Consumer Pharmaceutical Ads

According to the AMA, direct-to-consumer advertising of pharmaceuticals and medical devices drives up health care costs and should be banned. [More…]

Posted in Advertising, Antidepressant medication, Antipsychotic medication, Bipolar Depression, Bipolar Disorder, Depression, Direct-to-Consumer, Drug marketing, FDA, Health Industry, Mental health, News, Pharmaceutical Industry | Comments Off on AMA Moves to Ban Direct-To-Consumer Pharmaceutical Ads